C-peptide versus insulin: Relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Abdullah, A ^a   Hasan, H ^a   Raigangar, V ^a   Bani Issa, W ^a  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; URIC ACID;

ADULT; ARAB; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84864915507     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/420792     Document Type: Article

References (30)

1. The World Health Organization, The top 10 causes of death. March, 2012, http://www.who.int/mediacentre/factsheets/fs310/en/index2.html
2. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity Circulation 2009 120 16 1640 1645
3. Alberti K. G. M. M., Zimmet P., Shaw J., Metabolic syndromea new world-wide definition. A consensus statement from the International Diabetes Federation Diabetic Medicine 2006 23 5 469 480
4. Bajaj M., Suraamornkul S., Kashyap S., Cusi K., Mandarino L., DeFronzo R. A., Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes Journal of Clinical Endocrinology and Metabolism 2004 89 9 4649 4655 (Pubitemid 39244483)
5. Ballantyne C. M., Hoogeveen R. C., McNeill A. M., Heiss G., Schmidt M. I., Duncan B. B., Pankow J. S., Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study International Journal of Obesity 2008 32 2 S21 S24
6. Beckman J. A., Creager M. A., Libby P., Diabetes and atherosclerosis epidemiology, pathophysiology, and management Journal of the American Medical Association 2002 287 19 2570 2581 (Pubitemid 34517204)
7. Steiner D. F., Evidence for a precursor in the biosynthesis of insulin Transactions of the New York Academy of Sciences 1967 30 1 60 68
8. Steiner D. F., Park S. Y., Sty J., Philipson L. H., Bell G. I., A brief perspective on insulin production Diabetes, Obesity and Metabolism 2009 11 supplement 4 189 196
9. Pramanik A., Ekberg K., Zhong Z., Shafqat J., Henriksson M., Jansson O., Tibell A., Tally M., Wahren J., Jrnvall H., Rigler R., Johansson J., C-peptide binding to human cell membranes: importance of Glu27 Biochemical and Biophysical Research Communications 2001 284 1 94 98 (Pubitemid 32926739)
10. Hills C. E., Al-Rasheed N., Al-Rasheed N., Willars G. B., Brunskill N. J., C-peptide reverses TGF- 1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy American Journal of Physiology 2009 296 3 F614 F621
11. Wahren J., Ekberg K., Jrnvall H., C-peptide is a bioactive peptide Diabetologia 2007 50 3 503 509 (Pubitemid 46215490)
12. Wahren J., Shafqat J., Johansson J., Chibalin A., Ekberg K., Jrnvall H., Molecular and cellular effects of C-peptidenew perspectives on an old peptide Experimental Diabesity Research 2004 5 1 15 23 (Pubitemid 38488732)
13. Ahima R. S., Adipose tissue as an endocrine organ. Obesity 2006 14 supplement 5 S42S 249S
14. Lee J. M., Kim S. R., Yoo S. J., Hong O. K., Son H. S., Chang S. A., The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes Journal of International Medical Research 2009 37 6 1803 1812
15. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P., Adiponectin: a key adipocytokine in metabolic syndrome Clinical Science 2006 110 3 267 278 (Pubitemid 43341630)
16. Kressel G., Trunz B., Bub A., Hlsmann O., Wolters M., Lichtinghagen R., Stichtenoth D. O., Hahn A., Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk Atherosclerosis 2009 202 1 263 271
17. Jin M., Yang F., Yang I., Yin Y., Luo J. J., Wang H., Yang X.-F., Uric acid, hyperuricemia and vascular diseases Frontiers in Bioscience 2012 17 2 656 669
18. Panarotto D., Ardilouze J. L., Tessier D., Maheux P., The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm Metabolism 2000 49 8 1055 1062 (Pubitemid 30641445)
19. Lichnovsk R., Gwozdziewiczov S., Chlup R., Hrebcek J., Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic 2005 149 1 119 126
20. World Health organization (WHO), BMI classification. April 2012, http://apps.who.int/bmi/index.jsp?introPage=intro3.html
21. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 7 412 419 (Pubitemid 15018832)
22. Esteghamati A., Ashraf H., Khalilzadeh O., Zandieh A., Nakhjavani M., Rashidi A., Haghazali M., Asgari F., Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) Nutrition and Metabolism 2010 7, article 26
23. Li W. C., Hsiao K. Y., Chen I. C., Chang Y. C., Wang S. H., Wu K. H., Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults Cardiovascular Diabetology 2011 10, article 36
24. Grundy S. M., Brewer H. B., Cleeman J. I., Smith S. C., Lenfant C., Definition of metabolic syndrome-report of the national heart lung and blood institute/ American heart association conference on scientific issues related to definition Circulation 2004 109 3 433 438 (Pubitemid 38133916)
25. Ridker P. M., Buring J. E., Cook N. R., Rifai N., C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 2003 107 3 391 397
26. Sumino H., Ichikawa S., Kanda T., Nakamura T., Sakamaki T., Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia The Lancet 1999 354 9179 650 (Pubitemid 29391436)
27. Licinio-Paixao J., Polonsky K. S., Given B. D., Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide Journal of Clinical Endocrinology and Metabolism 1986 63 2 401 403 (Pubitemid 16035688)
28. Gumbiner B., Polonsky K. S., Beltz W. F., Griver K., Wallace P., Brechtel G., Henry R. R., Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism 1990 70 6 1594 1602
29. Faber O. K., Hagen C., Binder C., Kinetics of human connecting peptide in normal and diabetic subjects Journal of Clinical Investigation 1978 62 1 197 203 (Pubitemid 8367353)
30. Razvan V., Ifrim S., Ionescu-Tirgoviste C., Association of proinsulin with cardiovascular risk in nondiabetic subjects Proceedings of the Romanian Academy B 2011 2 129 136